Treatment of hemodialyzed patient with sunitinib

Ann Oncol. 2009 Feb;20(2):392-3. doi: 10.1093/annonc/mdn734. Epub 2009 Jan 8.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Anemia / chemically induced
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Renal Cell / surgery
  • Carcinoma, Renal Cell / therapy*
  • Coronary Artery Bypass / methods
  • Diarrhea / chemically induced
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Humans
  • Hypertension / chemically induced
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Male
  • Middle Aged
  • Nausea / chemically induced
  • Nephrectomy
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects*
  • Remission Induction / methods
  • Renal Dialysis*
  • Sunitinib
  • Thrombocytopenia / chemically induced
  • Treatment Outcome
  • Vomiting / chemically induced

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib